Verve Therapeutics Statistics

Total Valuation

NANOOMTECH has a market cap or net worth of KRW 11.02 billion.

Market Cap	11.02B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Dec 27, 2024

Share Statistics

NANOOMTECH has 5.02 million shares outstanding.

Current Share Class	5.02M
Shares Outstanding	5.02M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	41.39%
Owned by Institutions (%)	n/a
Float	2.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.69
PB Ratio	2.99
P/TBV Ratio	3.31
P/FCF Ratio	79.13
P/OCF Ratio	46.45
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.85.

Current Ratio	1.63
Quick Ratio	1.11
Debt / Equity	0.85
Debt / EBITDA	17.11
Debt / FCF	22.55
Interest Coverage	-2.64

Financial Efficiency

Return on equity (ROE) is -7.55% and return on invested capital (ROIC) is -2.56%.

Return on Equity (ROE)	-7.55%
Return on Assets (ROA)	-2.35%
Return on Invested Capital (ROIC)	-2.56%
Return on Capital Employed (ROCE)	-6.54%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.84
Inventory Turnover	2.76

Taxes

In the past 12 months, NANOOMTECH has paid 1.37 million in taxes.

Income Tax	1.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.61% in the last 52 weeks. The beta is 0.05, so NANOOMTECH's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-15.61%
50-Day Moving Average	2,154.50
200-Day Moving Average	2,151.15
Relative Strength Index (RSI)	54.61
Average Volume (20 Days)	96

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NANOOMTECH had revenue of KRW 6.51 billion and -288.89 million in losses. Loss per share was -2,889.02.

Revenue	6.51B
Gross Profit	2.97B
Operating Income	-291.09M
Pretax Income	-287.52M
Net Income	-288.89M
EBITDA	183.53M
EBIT	-291.09M
Loss Per Share	-2,889.02

Balance Sheet

The company has 1.84 billion in cash and 3.14 billion in debt, giving a net cash position of -1.30 billion or -258.49 per share.

Cash & Cash Equivalents	1.84B
Total Debt	3.14B
Net Cash	-1.30B
Net Cash Per Share	-258.49
Equity (Book Value)	3.68B
Book Value Per Share	34,413.28
Working Capital	1.91B

Cash Flow

In the last 12 months, operating cash flow was 237.20 million and capital expenditures -97.95 million, giving a free cash flow of 139.25 million.

Operating Cash Flow	237.20M
Capital Expenditures	-97.95M
Free Cash Flow	139.25M
FCF Per Share	27.74

Margins

Gross margin is 45.68%, with operating and profit margins of -4.47% and -4.44%.

Gross Margin	45.68%
Operating Margin	-4.47%
Pretax Margin	-4.42%
Profit Margin	-4.44%
EBITDA Margin	2.82%
EBIT Margin	-4.47%
FCF Margin	2.14%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 4.57%.

Dividend Per Share	100.00
Dividend Yield	4.57%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	4.57%
Earnings Yield	-2.62%
FCF Yield	1.26%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NANOOMTECH has an Altman Z-Score of 1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1
Piotroski F-Score	2